PT Multi Indocitra Tbk Logo

PT Multi Indocitra Tbk

MICE.JK

(2.8)
Stock Price

515 IDR

3.15% ROA

5.03% ROE

8.02x PER

Market Cap.

307.790.080.000 IDR

37.24% DER

0.96% Yield

3.59% NPM

PT Multi Indocitra Tbk Stock Analysis

PT Multi Indocitra Tbk Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

PT Multi Indocitra Tbk Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.4x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (38%), which means it has a small amount of debt compared to the ownership it holds

3 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

4 ROE

The stock's ROE falls within an average range (5.56%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (3.48%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

7 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

8 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (44.989) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

11 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

PT Multi Indocitra Tbk Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

PT Multi Indocitra Tbk Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

PT Multi Indocitra Tbk Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

PT Multi Indocitra Tbk Revenue
Year Revenue Growth
2007 243.820.965.081
2008 307.869.644.966 20.8%
2009 340.462.501.331 9.57%
2010 423.343.474.244 19.58%
2011 465.313.644.815 9.02%
2012 560.033.423.985 16.91%
2013 591.342.580.167 5.29%
2014 528.357.952.839 -11.92%
2015 555.215.582.347 4.84%
2016 641.282.717.147 13.42%
2017 570.153.318.185 -12.48%
2018 637.904.730.815 10.62%
2019 733.816.419.249 13.07%
2020 654.285.313.569 -12.16%
2021 770.708.092.995 15.11%
2022 974.636.523.540 20.92%
2023 1.104.333.358.508 11.74%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

PT Multi Indocitra Tbk Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

PT Multi Indocitra Tbk General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 234.868.601.234 100%
2013 239.026.430.585 1.74%
2014 243.716.363.520 1.92%
2015 263.898.829.238 7.65%
2016 306.664.638.997 13.95%
2017 1.433.908.867 -21286.62%
2018 1.783.107.307 19.58%
2019 1.897.117.361 6.01%
2020 805.427.816 -135.54%
2021 1.380.801.538 41.67%
2022 5.205.420.621 73.47%
2023 121.083.321.188 95.7%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

PT Multi Indocitra Tbk EBITDA
Year EBITDA Growth
2007 45.118.719.908
2008 41.887.469.093 -7.71%
2009 42.966.355.857 2.51%
2010 47.836.583.640 10.18%
2011 54.721.972.150 12.58%
2012 65.606.273.852 16.59%
2013 68.061.517.826 3.61%
2014 62.900.638.144 -8.2%
2015 46.025.910.075 -36.66%
2016 57.748.172.720 20.3%
2017 55.448.669.228 -4.15%
2018 76.374.215.324 27.4%
2019 65.007.391.925 -17.49%
2020 78.135.598.873 16.8%
2021 82.934.754.140 5.79%
2022 118.383.487.987 29.94%
2023 114.694.424.144 -3.22%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

PT Multi Indocitra Tbk Gross Profit
Year Gross Profit Growth
2007 123.599.256.339
2008 150.912.590.717 18.1%
2009 178.202.773.956 15.31%
2010 229.593.379.927 22.38%
2011 261.970.965.376 12.36%
2012 299.356.871.045 12.49%
2013 312.285.580.249 4.14%
2014 299.763.817.453 -4.18%
2015 299.624.398.997 -0.05%
2016 351.009.093.212 14.64%
2017 313.555.130.564 -11.94%
2018 355.716.127.655 11.85%
2019 384.212.858.532 7.42%
2020 371.865.498.483 -3.32%
2021 406.126.894.216 8.44%
2022 483.398.715.292 15.99%
2023 537.498.825.368 10.07%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

PT Multi Indocitra Tbk Net Profit
Year Net Profit Growth
2007 30.012.339.446
2008 23.940.967.953 -25.36%
2009 30.344.947.163 21.1%
2010 28.153.692.778 -7.78%
2011 30.021.501.205 6.22%
2012 40.655.581.627 26.16%
2013 40.044.210.651 -1.53%
2014 38.612.493.028 -3.71%
2015 23.344.376.122 -65.4%
2016 20.749.016.873 -12.51%
2017 66.627.067.011 68.86%
2018 32.998.409.722 -101.91%
2019 37.032.717.305 10.89%
2020 2.697.762.418 -1272.72%
2021 30.119.298.655 91.04%
2022 47.712.090.745 36.87%
2023 49.822.286.052 4.24%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

PT Multi Indocitra Tbk Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 50
2008 40 -28.21%
2009 51 22%
2010 47 -6.38%
2011 50 6%
2012 68 26.47%
2013 67 -1.49%
2014 63 -6.35%
2015 39 -61.54%
2016 35 -11.43%
2017 112 68.47%
2018 55 -101.82%
2019 62 11.29%
2020 5 -1450%
2021 51 92%
2022 81 37.5%
2023 84 4.76%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

PT Multi Indocitra Tbk Free Cashflow
Year Free Cashflow Growth
2007 -6.827.561.568
2008 -35.998.874.032 81.03%
2009 -36.439.896.481 1.21%
2010 -24.856.881.900 -46.6%
2011 -61.549.017.408 59.61%
2012 16.504.231.601 472.93%
2013 829.127.557 -1890.55%
2014 19.134.136.736 95.67%
2015 -34.211.178.494 155.93%
2016 -6.284.529.427 -444.37%
2017 -21.032.814.130 70.12%
2018 -141.526.488.842 85.14%
2019 -32.797.758.389 -331.51%
2020 39.191.007.946 183.69%
2021 9.232.916.666 -324.47%
2022 53.447.381.123 82.73%
2023 21.859.050.883 -144.51%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

PT Multi Indocitra Tbk Operating Cashflow
Year Operating Cashflow Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 39.279.711.264 100%
2013 16.321.539.241 -140.66%
2014 39.235.010.935 58.4%
2015 -6.221.799.203 730.61%
2016 45.991.870.765 113.53%
2017 5.049.117.127 -810.89%
2018 -41.564.156.522 112.15%
2019 19.939.168.008 308.45%
2020 45.961.019.849 56.62%
2021 29.553.260.078 -55.52%
2022 65.348.175.476 54.78%
2023 30.852.459.763 -111.81%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

PT Multi Indocitra Tbk Capital Expenditure
Year Capital Expenditure Growth
2007 6.827.561.568
2008 35.998.874.032 81.03%
2009 36.439.896.481 1.21%
2010 24.856.881.900 -46.6%
2011 61.549.017.408 59.61%
2012 22.775.479.663 -170.24%
2013 15.492.411.684 -47.01%
2014 20.100.874.199 22.93%
2015 27.989.379.291 28.18%
2016 52.276.400.192 46.46%
2017 26.081.931.257 -100.43%
2018 99.962.332.320 73.91%
2019 52.736.926.397 -89.55%
2020 6.770.011.903 -678.98%
2021 20.320.343.412 66.68%
2022 11.900.794.353 -70.75%
2023 8.993.408.880 -32.33%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

PT Multi Indocitra Tbk Equity
Year Equity Growth
2007 196.978.902.863
2008 208.589.903.816 5.57%
2009 226.837.070.979 8.04%
2010 257.576.939.761 11.93%
2011 273.278.288.966 5.75%
2012 302.000.410.593 9.51%
2013 440.888.836.967 31.5%
2014 473.534.599.995 6.89%
2015 528.644.119.721 10.42%
2016 546.807.399.844 3.32%
2017 607.387.806.141 9.97%
2018 637.711.996.421 4.76%
2019 678.855.033.425 6.06%
2020 680.711.709.737 0.27%
2021 710.571.586.064 4.2%
2022 749.014.831.925 5.13%
2023 776.916.622.825 3.59%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

PT Multi Indocitra Tbk Assets
Year Assets Growth
2007 249.021.297.327
2008 268.629.094.439 7.3%
2009 291.306.234.760 7.78%
2010 371.830.882.852 21.66%
2011 432.600.974.108 14.05%
2012 469.330.133.864 7.83%
2013 628.738.165.030 25.35%
2014 664.178.195.746 5.34%
2015 761.521.834.947 12.78%
2016 848.612.119.839 10.26%
2017 863.182.442.302 1.69%
2018 928.832.007.829 7.07%
2019 1.039.470.200.853 10.64%
2020 1.000.283.894.657 -3.92%
2021 1.063.137.390.963 5.91%
2022 1.196.101.828.789 11.12%
2023 1.219.195.973.682 1.89%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

PT Multi Indocitra Tbk Liabilities
Year Liabilities Growth
2007 30.691.933.976
2008 35.990.699.808 14.72%
2009 39.334.133.611 8.5%
2010 86.126.123.882 54.33%
2011 126.444.819.417 31.89%
2012 130.159.153.184 2.85%
2013 133.335.728.122 2.38%
2014 132.688.970.517 -0.49%
2015 177.549.579.466 25.27%
2016 247.798.771.622 28.35%
2017 255.800.228.951 3.13%
2018 291.120.011.408 12.13%
2019 360.615.167.428 19.27%
2020 319.572.184.920 -12.84%
2021 352.565.804.899 9.36%
2022 447.086.996.864 21.14%
2023 442.279.350.857 -1.09%

PT Multi Indocitra Tbk Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1808.87
Net Income per Share
64.85
Price to Earning Ratio
8.02x
Price To Sales Ratio
0.29x
POCF Ratio
4.57
PFCF Ratio
6.53
Price to Book Ratio
0.4
EV to Sales
0.5
EV Over EBITDA
4.87
EV to Operating CashFlow
8
EV to FreeCashFlow
11.43
Earnings Yield
0.12
FreeCashFlow Yield
0.15
Market Cap
308 Bil.
Enterprise Value
538 Bil.
Graham Number
1383.91
Graham NetNet
-346.13

Income Statement Metrics

Net Income per Share
64.85
Income Quality
4.33
ROE
0.05
Return On Assets
0.03
Return On Capital Employed
0.1
Net Income per EBT
0.72
EBT Per Ebit
0.63
Ebit per Revenue
0.08
Effective Tax Rate
0.28

Margins

Sales, General, & Administrative to Revenue
0.08
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.48
Operating Profit Margin
0.08
Pretax Profit Margin
0.05
Net Profit Margin
0.04

Dividends

Dividend Yield
0.01
Dividend Yield %
0.96
Payout Ratio
0
Dividend Per Share
5

Operating Metrics

Operating Cashflow per Share
113.67
Free CashFlow per Share
79.58
Capex to Operating CashFlow
-0.3
Capex to Revenue
-0.02
Capex to Depreciation
-4.56
Return on Invested Capital
0.06
Return on Tangible Assets
0.03
Days Sales Outstanding
0
Days Payables Outstanding
65.63
Days of Inventory on Hand
232.95
Receivables Turnover
0
Payables Turnover
5.56
Inventory Turnover
1.57
Capex per Share
-34.08

Balance Sheet

Cash per Share
102,78
Book Value per Share
1.312,55
Tangible Book Value per Share
1312.07
Shareholders Equity per Share
1312.55
Interest Debt per Share
532.9
Debt to Equity
0.37
Debt to Assets
0.24
Net Debt to EBITDA
2.09
Current Ratio
1.63
Tangible Asset Value
777 Bil.
Net Current Asset Value
212 Bil.
Invested Capital
0.37
Working Capital
252 Bil.
Intangibles to Total Assets
0
Average Receivables
0 Bil.
Average Payables
98 Bil.
Average Inventory
356799427956.5
Debt to Market Cap
0.94

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

PT Multi Indocitra Tbk Dividends
Year Dividends Growth
2006 10
2007 15 33.33%
2008 20 25%
2009 20 0%
2010 20 0%
2011 24 16.67%
2012 20 -20%
2013 15 -33.33%
2014 10 -50%
2015 10 0%
2017 10 0%
2018 10 0%
2019 10 0%
2020 5 -100%
2021 4 -25%
2022 15 73.33%
2023 5 -200%

PT Multi Indocitra Tbk Profile

About PT Multi Indocitra Tbk

PT Multi Indocitra Tbk produces and distributes baby and health care products, and cosmetics in Indonesia. The company offers baby and healthcare products, including bottle, nipple, breast feeding accs, feeding accs, nursing accs, healthcare accs, teether, pacifier, breast pads and pumps, baby wipes, baby and kids toiletries, baby skin care products, and adult and baby diapers; personal care products, such as face and compact powder, two way cake, facial foam, moisturizer, shower cream, bubble foam shower, handwash, hand and body lotions, shaver and refill cartridges, face and body cleansers, nipple cream and shields, breastmilk storage bags, natural oil skin repair, and breast therapy products; and cosmetics, which includes hand gels, lip care, lipstiks, eyes shadows, and make up products, as well as viva face tonic, milk cleansers, scin foods, air mawar, eye brow pencils, and liquid foundations. It also provides food and beverage products, including lexus, oat crunch, samudra, crackers, topmix, and funmixed munchy's; ota moruku, crack potato, miaow-miaow, omypop, and mini rice crack potatoes; waisun, southern, marshmallow, and lot sour 100 candies; d'best birdness, guava, tea, soya starway, dolphin, and wanfa drink beverages; ready to drink soya and sterile milk; and cooking spices and kitchen products. In addition, the company offers hotwheels, barbie, thomas & friends, fisher price, and mega bloks; pregnancy and fertility period test kits; contraception products; gummy vitamin for kids, adult, beauty, and expectant mom; air fresheners; glass cleaners; Toilet and bathroom cleaners; and furniture and motor vehicles maintenance products; lampu LEDs, daylight and warmwhite bulbs, and flood lights; plates and bowls; and 3Ply maskers and hand sanitizer sprays. It sells its brands under the Pigeon and Lock&Lock brands name. PT Multi Indocitra Tbk was founded in 1990 and is headquartered in Jakarta Barat, Indonesia.

CEO
Mr. Anthony Honoris
Employee
392
Address
Green Central City
Jakarta Barat, 11120

PT Multi Indocitra Tbk Executives & BODs

PT Multi Indocitra Tbk Executives & BODs
# Name Age
1 Mr. Anthony Honoris
President Director
70
2 Mr. Ali Arifin
Company Secretary
70
3 Mr. Tony Sunaryo
Head of Internal Audit Unit
70

PT Multi Indocitra Tbk Competitors